GPS Wealth Strategies Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64K | Hold |
100
| – | – | ﹤0.01% | 1268 |
|
|
2025
Q1 | $3.62K | Hold |
100
| – | – | ﹤0.01% | 1224 |
|
|
2024
Q4 | $4.21K | Hold |
100
| – | – | ﹤0.01% | 1125 |
|
|
2024
Q3 | $5.56K | Hold |
100
| – | – | ﹤0.01% | 1080 |
|
|
2024
Q2 | $4.11K | Hold |
100
| – | – | ﹤0.01% | 1100 |
|
|
2024
Q1 | $4.67K | Hold |
100
| – | – | ﹤0.01% | 1011 |
|
|
2023
Q4 | $4.78K | Hold |
100
| – | – | ﹤0.01% | 989 |
|
|
2023
Q3 | $3.57K | Hold |
100
| – | – | ﹤0.01% | 1033 |
|
|
2023
Q2 | $4.61K | Hold |
100
| – | – | ﹤0.01% | 1002 |
|
|
2023
Q1 | $4.01K | Buy |
+100
| New | +$4.01K | ﹤0.01% | 1015 |
|
|
2022
Q4 | – | Sell |
-100
| Closed | -$4K | – | 862 |
|
|
2022
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 947 |
|
|
2022
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 857 |
|
|
2022
Q1 | $7K | Hold |
100
| – | – | ﹤0.01% | 799 |
|
|
2021
Q4 | $8K | Hold |
100
| – | – | ﹤0.01% | 782 |
|
|
2021
Q3 | $9K | Hold |
100
| – | – | ﹤0.01% | 744 |
|
|
2021
Q2 | $10K | Hold |
100
| – | – | ﹤0.01% | 733 |
|
|
2021
Q1 | $11K | Buy |
+100
| New | +$11K | ﹤0.01% | 659 |
|